Original Article

Early Results of the Persian Registry of Cardiovascular Disease/Congenital Heart Disease (PROVE/CHD) in Isfahan


Background: In 2016, a prospective registry for pediatric patients with congenital heart disease (CHD) was established in Isfahan, Iran. Data on pediatric CHD in Iran are scant; accordingly, we aimed to report the early results of the Persian Registry Of cardioVascular diseasE (PROVE/CHD) Registry in Isfahan.

Methods: All patients with CHD and associated defects diagnosed by pediatric cardiologists were assessed via echocardiography for inclusion in the present study between late 2016 and August 2019. The participants’ sociodemographic characteristics, maternal history, birth history, medical history, current clinical presentations in the clinic or hospital, paraclinical data, cardiac diagnoses based on the International Classification of Diseases, 10th Revision (ICD-10), disease management plans, and medications were entered into a questionnaire by the subjects’ parents/legal custodians and physicians and then transferred to the PROVE/CHD Registry.

Results: The PROVE/CHD registry encompasses 1252 patients with CHD (49.9% male) at a mean age of 6.50±6.36 years. The most frequent cardiac diagnoses were ventricular septal defect (39.3%), atrial septal defect (29.7%), patent ductus arteriosus (25.4%), pulmonary stenosis (11.0%), tetralogy of Fallot (6.1%), coarctation of the aorta (5.4%), and aortic stenosis (5.1%), respectively. The most frequent interventions were patent ductus arteriosus closure (4.3%), atrial septal defect closure (3.6%), pulmonary valvuloplasty (2.2%), coarctation of the aorta angioplasty (1.9%), and ventricular septal defect closure (1.1%), correspondingly. The approximate corresponding rates of corrective and palliative surgeries were 32.0% and 13.1%. The corrective surgeries were mainly comprised of ventricular septal defect closure (7.8%), patent ductus arteriosus closure (7.3%), atrial septal defect closure (5.1%), and tetralogy of Fallot repair (3.8%), respectively. The palliative surgeries mainly consisted of the Glenn shunt (9.0%) and pulmonary artery banding (3.6%).

Conclusion: The PROVE/CHD Registry collects data on pediatric patients with CHD. The results of this registry can provide epidemiological data and a set of homogeneously defined cases for further studies.

1. Zhao Q-M, Liu F, Wu L, Ma X-J, Niu C, Huang G-Y. Prevalence of congenital heart disease at live birth in China. The Journal of pediatrics 2019;204:53-58.
2. Lage K, Greenway SC, Rosenfeld JA, Wakimoto H, Gorham JM, Segrè AV, Roberts AE, Smoot LB, Pu WT, Pereira AC, Mesquita SM. Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development. Proceedings of the National Academy of Sciences 2012;109:14035-14040.
3. Zeng Z, Zhang H, Liu F, Zhang N. Current diagnosis and treatments for critical congenital heart defects. Exp Ther Med. 2016;11:1550-1554.
4. Garne E, Stoll C, Clementi M. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 2001;17:386-391.
5. Greutmann M, Tobler D, Kovacs AH, Greutmann‐Yantiri M, Haile SR, Held L, Ivanov J, Williams WG, Oechslin EN, Silversides CK, Colman JM. Increasing mortality burden among adults with complex congenital heart disease. Congenital heart disease 2015;10:117-127.
6. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, et al. Mortality in adult congenital heart disease. European heart journal 2010;31:1220-1229.
7. Vander Velde E, Vriend J, Mannens M, Uiterwaal C, Brand R, Mulder BJ. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. European journal of epidemiology 2005;20:549-557.
8. Givi M, Sarrafzadegan N, Garakyaraghi M, Yadegarfar G, Sadeghi M, Khosravi A, Azhari AH, Samienasab MR, Shafie D, Saadatnia M, Roohafza H. Persian registry of cardiovascular disease (PROVE): Design and methodology. ARYA atherosclerosis 2017;1):236.
9. Dehghan B, Sabri MR, Hosseinzadeh M, Ahmadi A, Ghaderian M, Sarrafzadegan N, Roohafza H. The commencement of congenital heart diseases registry in Isfahan, Iran: Methodology and design. ARYA Atheroscler 2020;16: 244-247.
10. Best KE, Tennant PW, Rankin JJJotAHA. Survival, by birth weight and gestational age, in individuals with congenital heart disease: a population‐based study 2017;6:e005213.
11. Schulkey CE, Regmi SD, Magnan RA, Danzo MT, Luther H, Hutchinson AK, Panzer AA, Grady MM, Wilson DB, Jay PY. The maternal-age-associated risk of congenital heart disease is modifiable. Nature 2015;520:230-233.
12. Kalisch-Smith JI, Ved N, Sparrow DB. Environmental risk factors for congenital heart disease. Cold Spring Harbor Perspectives in Biology 2020;12:a037234.
13. Yang Y, Hou Y, Wang H, Gao X, Wang X, Li J, Teng W, Shan Z. Maternal Thyroid Dysfunction and Gestational Anemia Risk: Meta-Analysis and New Data. Front Endocrinol (Lausanne) 2020;11:201.
14. Pastor-García M, Gimeno-Martos S, Zurriaga Ó, Sorlí JV, Cavero-Carbonell C. Anomalías congénitas cardíacas en la Comunitat Valenciana 2007-2014, el registro poblacional de anomalías congénitas [Congenital heart defects in the Valencian Community 2007-2014: The Population-Based Registry Of Congenital Anomalies]. An Pediatr (Barc) 2020;92:13-20.
15. Ahmadi A, Gharipour M, Navabi ZS, Heydari H. Risk factors of congenital heart diseases: A hospital-based case-control study in Isfahan, Iran. ARYA Atheroscler 2020;16:1-6.
16. Bogarapu S, Pinto NM, Etheridge SP, Sheng X, Liesemer KN, Young PC, Saarel EV. Screening for Congenital Heart Disease in Infants with Down Syndrome: Is Universal Echocardiography Necessary? Pediatr Cardiol 2016;37:1222-1227.
17. Yaqoob M, Manzoor J, Hyder SN, Sadiq M. Congenital heart disease and thyroid dysfunction in Down syndrome reported at Children`s Hospital, Lahore, Pakistan. Turk J Pediatr 2019;61:915-924.
18. Desai K, Rabinowitz EJ, Epstein S. Physiologic diagnosis of congenital heart disease in cyanotic neonates. Curr Opin Pediatr 2019;31:274-283.
19. Mohammad N, Shaikh S, Memon S, Das H. Spectrum of heart disease in children under 5 years of age at Liaquat University Hospital, Hyderabad, Pakistan. Indian Heart J 2014;66:145-149.
20. Alabdulgader AA. Congenital heart disease in Saudi Arabia: current epidemiology and future projections. EMHJ;2006: 12(Supplement 2):157-167.
21. Gaskin K, Kennedy F. Care of infants, children and adults with congenital heart disease. Nurs Stand 201926;34:37-42.
22. Engelings CC, Helm PC, Abdul-Khaliq H, Asfour B, Bauer UM, Baumgartner H, Kececioglu D, Körten MA, Diller GP, Tutarel O. Cause of death in adults with congenital heart disease-An analysis of the German National Register for Congenital Heart Defects. Int J Cardiol 2016;211:31-36.
23. Mirzarahimi M, Saadati H, Doustkami H, Alipoor R, Isazadehfar K, Enteshari A. Heart murmur in neonates: how often is it caused by congenital heart disease? Iran J Pediatr 2011;21:103-106.
24. Qu Y, Liu X, Zhuang J, Chen G, Mai J, Guo X, Ou Y, Chen J, Gong W, Gao X, Wu Y, Nie Z. Incidence of Congenital Heart Disease: The 9-Year Experience of the Guangdong Registry of Congenital Heart Disease, China. PLoS One 2016;11:e0159257.
25. Calzolari E, Garani G, Cocchi G, Magnani C, Rivieri F, Neville A, Astolfi G, Baroncini A, Garavelli L, Gualandi F, Scorrano M, Bosi G; IMER Working Group. Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidemiol 2003;18:773-780.
26. Egbe A, Uppu S, Lee S, Stroustrup A, Ho D, Srivastava S. Temporal variation of birth prevalence of congenital heart disease in the United States. Congenit Heart Dis 2015;10:43-50.
27. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007;115:163-72.
28. Giannakoulas G, Vasiliadis K, Frogoudaki A, Ntellos C, Tzifa A, Brili S, Manginas A, Papaphylactou M, Parcharidou D, Kampouridis N, Pitsis A, Chamaidi A, Kolios M, Papadopoulos G, Douras A, Davlouros P, Ntiloudi D, Karvounis H, Kalangos A, Tsioufis C, Rammos S; CHALLENGE investigators. Adult congenital heart disease in Greece: Preliminary data from the CHALLENGE registry. Int J Cardiol 2017;245:109-113.
29. van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R, Mulder BJ. CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol 2005;20:549-557.
30. Nelle M, Raio L, Pavlovic M, Carrel T, Surbek D, Meyer-Wittkopf M. Prenatal diagnosis and treatment planning of congenital heart defects-possibilities and limits. World J Pediatr
IssueVol 15 No 4 (2020): J Teh Univ Heart Ctr QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/jthc.v15i4.5941
Heart defects; congenital Disease management Registries

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Ahmadi AR, Sabri MR, Navabi ZS, Ghaderian M, Dehghan B, Mahdavi C, Khodarahmi S. Early Results of the Persian Registry of Cardiovascular Disease/Congenital Heart Disease (PROVE/CHD) in Isfahan. J Tehran Heart Cent. 15(4):158-164.